These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1513153)

  • 1. Effects of oxygenated cardioplegic solutions on myocardial aerobic metabolism.
    DeBoer LW; Rabjohns RR; Nutt MP; Swanson DK
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):632-6. PubMed ID: 1513153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
    Tachibana H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
    Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.
    Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
    de Wit L; Coetzee A; Kotze J; Lochner A
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
    Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
    J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial recovery after hypothermic arrest: a comparison of oxygenated crystalloid to blood cardioplegia. The role of calcium.
    Heitmiller RF; DeBoer LW; Geffin GA; Toal KW; Fallon JT; Drop LJ; Teplick RS; O'Keefe DD; Daggett WM
    Circulation; 1985 Sep; 72(3 Pt 2):II241-53. PubMed ID: 4028363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution.
    Guyton RA; Dorsey LM; Craver JM; Bone DK; Jones EL; Murphy DA; Hatcher CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):877-87. PubMed ID: 3873582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation.
    Johnson DL; Greene PS; Gott VL; Gardner TJ
    Circulation; 1988 Nov; 78(5 Pt 2):III153-7. PubMed ID: 3180395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
    Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of glucose and oxygen in multidose cold cardioplegia.
    Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.